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Fruiting body lectins have been proposed 
to act as effector proteins in the defense of 
fungi against parasites and predators. The 
Marasmius oreades agglutinin (MOA) is a 
Galα1,3Gal/GalNAc-specific lectin from the 
fairy ring mushroom that consists of an N-
terminal, ricin B-type lectin domain and a C-
terminal dimerization domain. Latter domain 
shows structural similarity to catalytically 
active proteins, suggesting that, in addition to 
its carbohydrate-binding activity, MOA has 
an enzymatic function. Here, we demonstrate 
toxicity of MOA towards the model nematode 
Caenorhabditis elegans. This toxicity depends 
on binding of MOA to glycosphingolipids of 
the worm via its lectin domain. We further 
show that MOA has cysteine protease activity 
and demonstrate a critical role of this 
catalytic function for MOA-mediated 
nematotoxicity. The proteolytic activity of 
MOA was dependent on high Ca
2+ 
concentrations and favoured by slightly 
alkaline pH, suggesting that these conditions 
trigger activation of the toxin at the target 
location. Our results suggest that MOA is a 
fungal toxin with intriguing similarities to 
bacterial binary toxins and has a protective 
function against fungivorous soil nematodes. 
 
A wide variety of lectins with different 
structures and specificities has been isolated 
from fungi (1). Recently, cytoplasmic fungal 
lectins, also referred to as fruiting body lectins, 
were proposed to be part of a fungal defense 
system against parasites and predators. This 
hypothesis is based on the carbohydrate-binding 
dependent toxicity of several fungal lectins 
towards nematodes, insect larvae and amoebae 
(2). The exclusive and abundant expression of 
these lectins in fruiting bodies or sclerotia of the 
host fungus may result in a special protection of 
these reproductive organs. It is proposed that 
predators such as fungivorous nematodes ingest 
the cytoplasmic lectin when feeding on the 
content of the fungal cell and that binding of the 
lectin to specific glycans in the intestine of the 
worm induces toxicity by an unknown 
mechanism (2-5). 
The Marasmius oreades agglutinin (MOA) is 
a type B erythrocyte agglutinating lectin that was 
isolated from fruiting bodies of the fairy ring 
mushroom. The dimeric lectin consists of 293-
residue protomers and has been shown to 
specifically recognize Galα1,3-containing 
structures, exhibiting highest affinity for the 
branched blood group B trisaccharide 
Galα1,3(Fucα1,2)Gal (6). Crystal structures of 
MOA in complex with the xenotransplantation 
epitope and the blood group B trisaccharide 
revealed an N-terminal ricin B-type lectin 
domain with three canonical carbohydrate 
binding sites and a C-terminal domain that is 
involved in dimerization. The C-terminal domain 
showed structural homology to catalytically 
active proteins such as peptide-N-glycanases, N-
acetyltransferases, transglutaminases and 
cysteine proteases. This structural similarity was 
limited to a putative catalytic triade consisting of 
Cys215, His257 and Glu274 (7,8). However, no 
catalytic activity of MOA has been reported so 
far. Moreover, the biological target glycan and 
the function of the lectin remained unclear. Like 
other fruiting body lectins, MOA lacks a 
classical secretion signal and is thus predicted to 
be localized in the cytoplasm. An endogenous 
function of the lectin is therefore unlikely as 
glycosylated structures are generally secreted or 
localized in the extracellular space (9). 
Accordingly, no glycoconjugate recognized by 
MOA has thus far been identified in fungi. 
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In this study, we investigated the possible 
role of MOA as a fungal defense molecule 
against nematodes, using C. elegans as a 
genetically tractable model system. First, we 
demonstrate carbohydrate-binding dependent 
nematotoxicity of MOA and identify 
glycosphingolipids as the ligands of MOA in C. 
elegans. Second, we show that MOA-mediated 
toxicity is dependent on the previously suggested 
catalytic function that we identified as Ca
2+
 
dependent cysteine protease activity. Our results 
suggest that MOA is a fungal toxin that protects 
the fruiting body from predators such as 
fungivorous nematodes. 
 
EXPERIMENTAL PROCEDURES 
 
Strains, cultivation conditions, cloning and 
site-directed mutagenesis. Strains, primer 
sequences and experimental procedures can be 
found in SI Materials and Methods. 
C. elegans toxicity assays and statistical 
analysis. Biotoxicity assays with C. elegans 
were performed as described (10). Results were 
analyzed using a t-test for pairwise comparisons. 
Protein expression, purification and 
biotinylation. MOA and MOA(C215A) were 
expressed recombinantly in E. coli and purified 
as described (6,11). Detailed information can be 
found in SI Materials and Methods. t-Cry5B was 
prepared as previously described (12). For TLC 
overlay analysis, purified MOA and t-Cry5B 
were labeled with EZ-Link Sulfo-NHS-Biotin 
(Pierce) using a 20-fold molar excess of labeling 
reagent. Labeling proceeded for two hours on ice 
followed by desalting on a PD-10 column.  
Screen for MOA-resistant C. elegans mutants 
using Mos1 insertional mutagenesis and light 
microscopy of C. elegans. Mos1 insertional 
mutagenesis, stereomicroscopy and differential 
interference contrast (DIC) microscopy of C. 
elegans was performed as described (3). 
Preparation and analysis of glycolipids from 
C. elegans. Glycolipid extraction from C. 
elegans N2, bre-2 and bre-4 strains and TLC 
overlay staining was performed as described by 
Barrows et al (13). For overlay analysis 
biotinylated MOA and t-Cry5B were used at a 
concentration of 150nM.  
In vitro protease assay. Briefly, 20 μg of 
denatured RNase A was incubated with 0.1 ng to 
1 μg of purified recombinant MOA or 
MOA(C215A) in assay buffer (40 mM Tris-HCl 
pH 8.0, 1 mM CaCl2, 1% NP-40) in a final 
reaction volume of 30 μl for 1 h at 37 °C. 
Samples were analyzed by SDS-PAGE and 
Coomassie blue staining. Detailed information is 
provided in SI Materials and Methods. 
Cleavage site specificity. 40 µg of bovine 
asialofetuin, bovine casein and human 
hemoglobin were digested with 100 ng of MOA 
in 40mM Tris-HCl pH8.0, 1mM CaCl2 for 1h at 
37°C. The reaction was stopped by addition of 
25 mM EDTA. Samples were desalted using 
C18 ZipTips (Millipore) and analyzed on an 
LTQ-Orbitrap XL mass spectrometer (Thermo 
Fischer Scientific, Bremen, Germany) coupled to 
an Eksigent-Nano-HPLC system (Eksigent 
Technologies, Dublin (CA), USA). Detailed 
information on MS analysis and data evaluation 
is provided in SI Materials and Methods. 
 
RESULTS 
 
MOA inhibits C. elegans development and 
amoebal growth dependent on its carbohydrate-
binding ability. Based on the results with other 
fruiting body lectins (2), we tested MOA for 
toxicity towards the nematode Caenorhabditis 
elegans and the amoeba Acanthamoeba 
castellanii. These biotoxicity assays involved 
feeding of the organisms with MOA-expressing 
E. coli as described previously (10) and revealed 
a clear toxicity of MOA towards C. elegans and 
A. castellanii (Fig. 1; Fig. S1). Both C. elegans 
and A. castellanii were fed with E. coli cells 
expressing either authentic MOA, the C-terminal 
deletion mutant MOA(C) or the carbohydrate-
binding deficient variant MOA(Q46A,W138A) 
(7). In a control experiment, test organisms were 
grown on vector-containing E. coli 
transformants. In case of C. elegans, severe 
inhibition of larval development was observed 
for N2 wildtype and pmk-1(km25) mutant 
animals feeding on MOA-expressing bacteria 
compared to the vector control (p<0.05) (Fig. 
1A). The pmk-1(km25) mutation in the p38 
mitogen-activated protein kinase (MAPK) 
pathway was previously shown to cause 
hypersensitivity to different kinds of stress 
including exposure to fungal lectins (3). In 
contrast, MOA(Q46A,W138A) had no 
significant effect on the development of the 
worms (p>0.05). Similar results were obtained 
with A. castellanii (p<0.05) (Fig. S1). Previous 
studies showed that residues Q46 and W138 are 
involved in glycan coordination (7,8) and that 
the binding activity of the double mutant to 
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thyroglobulin is reduced compared to wild-type 
MOA (14). The lacking toxicity of 
MOA(Q46A,W138A) suggests that 
nematotoxicity of MOA is dependent on the 
carbohydrate-binding activity of the protein. 
This is also supported by the decreased 
nematotoxicity of MOA(C) (p<0.05), a mutant 
that showed reduced carbohydrate-binding 
activity possibly due to loss of dimerization (14) 
(Fig. 1A). 
Physiological effects of intoxication were 
studied by comparative light- and differential 
interference contrast (DIC) microscopy of C. 
elegans L4 larvae fed with MOA-expressing or 
vector-containing E. coli cells. MOA-intoxicated 
animals showed an expanded lumen of the 
anterior intestine compared to control animals 
(Fig. 1B). A similar phenotype was observed 
with other nematotoxic fungal lectins (3) and 
bacterial toxins (15). 
The ligand of MOA in C. elegans is a 
glycosphingolipid. In order to identify the target 
glycoconjugate of MOA in C. elegans, a forward 
genetic screen for mutations conferring MOA-
resistance was performed. Strain pmk-1(km25) 
was used to increase the sensitivity of the screen. 
Four MOA-resistant mutants were isolated in the 
screen, all of which carried mutations in exons 
of the bre-3 gene. Bre-3(op504) and bre-
3(op505) mutants had a Mos1 insertion in the 
seventh exon of bre-3. Bre-3(op506) mutants 
carried a Mos1 insertion in the fifth exon of the 
same gene. In an independent screen, one mutant 
(op508) with a Mos1 insertion site identical to 
the one of bre-3(op504) was identified (Fig. 2A). 
Bre-3 encodes for a glycosyltransferase that acts 
in a biosynthetic pathway building up an 
invertebrate-specific glycosphingolipid that is 
recognized by the Bacillus thuringiensis crystal 
toxin Cry5B (16). The oligosaccharide core of 
the ceramide-linked glycan is synthesized by the 
sequential action of BRE-3 (β1,4-
mannosyltransferase), BRE-5 (β1,3-GlcNAc-
transferase), BRE-4 (β1,4-GalNAc-transferase) 
and BRE-2 (putative β1,3-galactosyltransferase).  
Bre-1 encodes for an enzyme involved in the 
conversion of GDP-mannose into GDP-fucose 
(17). Given the resistance of bre-3 mutant 
animals we tested worms with mutations in the 
other bre-genes for sensitivity towards MOA. 
We observed that also mutations in bre-4(ye27) 
and bre-5(ye17) genes conferred resistance to 
MOA (p<0.05) whereas bre-1(ye4) and bre-
2(ye31) mutant worms were sensitive to 
intoxication with MOA (p>0.05) (Fig. 2B). 
These results suggest that fungal MOA, like 
bacterial Cry5B, targets a glycosphingolipid but 
that the species is different from the one 
recognized by Cry5B. 
In order to confirm the genetic data, direct 
binding of MOA to glycolipids isolated from N2, 
bre-2(ye31), and bre-4(ye27) mutant worms was 
assessed in a thin layer chromatography (TLC) 
overlay. For this purpose lipids were extracted 
from C. elegans, partitioned into lower phase 
lipids and upper phase glycolipids and 
subsequently purified as described by Barrows et 
al. (13). Purified glycolipids were separated by 
TLC using chloroform:methanol:water (4:4:1) as 
a solvent and visualized using Orcinol sulfate 
(Fig. 2C, lane 2-4). The main glycolipid bands 
were observed in positions similar to those 
reported previously (12,16). TLC overlay 
staining of upper phase glycolipids with MOA 
revealed binding to N2 and bre-2(ye31) but not 
to bre-4(ye27) glycolipids (Fig. 2C, lane 5-7). 
This is consistent with MOA-susceptibility of 
N2 and bre-2(ye31) worms and resistance of 
bre-4(ye27) animals. To identify the glycolipid 
species that is recognized by MOA, comparative 
overlay staining with truncated Cry5B (t-Cry5B) 
as described by Ideo et al. (12) was performed. 
The pattern of the Orcinol staining and the t-
Cry5B overlay of N2- derived glycolipids (Fig. 
2C, lane 1) indicated that the main glycolipid 
species recognized by MOA corresponds to 
component D according to the classification of 
Griffitts et al. that has been previously 
characterized (16,18). Binding to the glycan part 
of this glycosphingolipid of the arthroseries 
(Galα1,3GalNAcβ1,4GlcNAcβ1,3Manβ1,4Glc, 
Fig. 2D) (16,18) is in agreement with the 
Galα1,3Gal specificity of MOA. Finally, MS and 
MS/MS analysis of glycolipids extracted from 
the main TLC band recognized by MOA further 
supported the presence of component D 
including the ceramide moiety composed of a 
saturated hydroxy fatty acid with 22 and 24 
carbon atoms, respectively (Fig. S2). Besides 
component D, MOA is able to bind to a number 
of unidentified glycolipid species from both N2 
and bre-2(ye31) animals (Fig. 2C, lanes 5, 6). 
These glycolipid species are absent from the bre-
4(ye27) animals. 
MOA shows in vitro protease activity. X-ray 
crystallographic studies of MOA in complex 
with the xenotransplantation epitope and the 
blood group B trisaccharide revealed that the C-
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terminal part of MOA adopts a fold that is 
observed in catalytically active proteins such as 
peptide N-glycanases, N-acetyltransferases, 
transglutaminases and cysteine proteases (7,8). 
As the highest homology was observed to a 
peptide N-glycanase (PNGase) we tested 
purified recombinant MOA in an in vitro 
PNGase assay described by Suzuki (19). 
However, instead of deglycosylation of the 
glycoprotein RNase B, degradation of the 
substrate was observed, indicating that MOA 
may have protease- rather than peptide N-
glycanase activity. To confirm this hypothesis, 
we performed an in vitro protease assay with 
non-glycosylated RNase A as substrate (Fig. 3). 
MOA efficiently degraded denatured RNase A 
within 1 h at 37 °C. In contrast, MOA(C215A), 
in which the cysteine residue of the putative 
catalytic triad was replaced by an alanine, had no 
effect on RNase A, confirming that the observed 
protease activity was MOA-dependent. In 
accordance with these results, degradation of the 
substrate protein by MOA was abolished in the 
presence of 50 μM E-64, an irreversible, highly 
selective cysteine protease inhibitor, but not in 
the presence of 2 mM PMSF, an irreversible 
serine protease inhibitor or 2 mM AgNO3, a 
potent trypsin and chymotrypsin inhibitor (Fig. 
3A). Based on these results, we conclude that 
MOA has, in addition to its glycan-binding-
properties, cysteine protease activity. 
Structural homology to catalytically active 
proteins was first observed in a crystal structure 
of MOA in complex with the 
xenotransplantation epitope (7). A second crystal 
structure of MOA complexed with the blood 
group B trisaccharide revealed that binding of 
two Ca
2+
 ions close to the hypothetical active site 
in the C-terminal domain causes a 
conformational change opening up a large cleft 
containing the potential active site (8). To 
investigate the influence of divalent cations on 
MOA protease activity, reactions in assay buffer 
supplemented with 1mM CaCl2, MgCl2, MnCl2, 
and ZnCl2, respectively, were performed. In the 
presence of Ca
2+
 ions proteolytic degradation of 
RNase A by MOA was observed. In contrast, 
MOA showed hardly any activity in buffers 
supplemented with MgCl2, MnCl2 or ZnCl2 or in 
the absence of divalent cations (Fig. 3B). This 
observation is in accordance with the structural 
data and suggests that Ca
2+
 binding activates the 
catalytic activity of MOA. We found that a 
minimal concentration of 50 μM was required 
for MOA to exhibit protease activity and that 
this activity further increased upon raising the 
Ca
2+
 concentration up to 5 mM (Fig. S3). 
To test the influence of the pH on the 
reaction, protease assays in buffers of different 
pH-values were performed. Complete 
degradation of RNase A by MOA was observed 
at pH 8.0. At higher pH, MOA only partially 
degraded the substrate whereas under acidic 
conditions the enzyme was not active (Fig. 3C). 
Therefore MOA protease activity is favoured by 
a slightly alkaline pH. Presence or absence of the 
carbohydrate ligand Galα1,3Galβ1,4GlcNAc did 
not affect the proteolytic activity of MOA (Fig. 
S4). 
In order to characterize the substrate 
specificity of MOA, we tested its activity 
towards different denatured and native protein 
substrates in the in vitro assay. Bovine serum 
albumin (BSA), fluorescein isothiocyanate 
(FITC) labeled casein, asialofetuin, and 
hemoglobin were degraded when denatured 
before incubation with MOA (Fig. S5A). In the 
native state, only FITC-casein, asialofetuin and 
hemoglobin were susceptible to MOA protease 
activity whereas BSA, RNase A and RNase B 
were not degraded (Fig. S5B). Proteolytic 
degradation of FITC-casein by MOA could also 
be detected in a fluorometric assay, where it 
showed a 3.6 fold higher activity/mole at pH 8.0 
than the cysteine protease papain at pH 7.5 (Fig. 
S6). As MOA did not act on every tested native 
protein substrate we conclude that the protease 
has a certain substrate specificity.  
To investigate the cleavage site specificity of 
MOA, native asialofetuin, casein or hemoglobin 
were digested with purified MOA and the 
resulting peptides were analyzed by LC-ESI-
MS/MS. This procedure yielded 83 cleavage 
sites that were used to create an iceLogo (20) of 
the preferred sequence specificity, where the 
cleavage occurs between position 4 and 5 (Fig. 
3D). The results of this analysis suggest that 
MOA prefers proline and proline or valine at 
position 0 and 2, respectively. A digest of C. 
elegans proteome with MOA yielded similar 
results (data not shown), confirming the 
specificity observed for the model substrates. 
Protease activity of MOA is required for 
nematotoxicity. To test whether the protease 
activity of MOA plays a role in toxicity towards 
C. elegans, worms were fed with E. coli 
expressing the catalytic site mutant 
MOA(C215A). This single site mutant forms 
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dimers like wild-type MOA as confirmed by 
analytical gel filtration (Fig. S7). The toxicity of 
MOA(C215A) was significantly reduced in N2 
animals and pmk-1(km25) mutants compared to 
wild-type MOA (p<0.05) (Fig. 4A). Similar 
results were obtained for A. castellanii (p<0.05) 
(Fig. S1). Based on these results, we conclude 
that, in addition to carbohydrate-binding, the 
cysteine protease activity of MOA is necessary 
for full toxicity. In C. elegans, the contribution 
of the catalytic domain to the toxicity of MOA is 
also apparent by the fact that pmk-1(km25) 
mutant and N2 wild type worms are equally 
susceptible towards wild-type MOA (Fig 1A, Fig 
4A). This is in contrast to nematotoxic fungal 
lectins lacking a catalytic domain which display 
a higher toxicity to pmk-1(km25) mutant worms 
(2,3). Accordingly, abolishment of the catalytic 
activity, as in the case of MOA(C215A) and 
MOA(C), results in higher susceptibility of 
pmk-1(km25) worms compared to N2 worms 
((Fig 1A, Fig 4A). The higher toxicity of 
MOA(C215A) in comparison to MOA(C) can 
be explained by the lack of dimerization in latter 
case. These results suggest that the toxicity 
mechanism of MOA differs from the one of 
nematotoxic lectins without a catalytic domain.  
As the protease activity of MOA could be 
inhibited by E-64 in vitro, pmk-1(km25) animals 
were grown on MOA expressing bacteria in the 
presence of 10 to 500 μM of this highly selective 
cysteine protease inhibitor. The cell-permeable 
inhibitor significantly reduced MOA-mediated 
toxicity in a dose-dependent manner. On the 
other hand, E-64 did not impair development of 
worms feeding on vector-containing E. coli (Fig. 
4B). These results confirm the role of MOA 
cysteine protease activity in nematotoxicity. As 
observed for the catalytic site mutant in the case 
of pmk-1(km25) worms, toxicity was not 
completely abolished by inhibiting protease 
activity even at the highest concentration of E-
64. Remaining toxicity at inhibitor 
concentrations higher than 50 μM can be 
referred to the toxicity mediated by the lectin 
domains of the dimer, which are not affected by 
E-64. 
 
DISCUSSION 
 
Fruiting body lectins have been proposed to 
be part of the fungal defense system against 
predators and parasites (2). In agreement with 
such a function, we demonstrate that the fruiting 
body lectin MOA is toxic towards the nematode 
C. elegans and the amoeba A. castellanii. As 
MOA mutants deficient in carbohydrate-binding 
exhibited no or significantly reduced toxicity for 
both organisms, we conclude that the lectin-
activity of the protein is essential for its toxicity. 
Morphological changes of MOA-intoxicated 
worms include an enlargement of the intestinal 
lumen, an effect that has previously been 
reported for the fungal lectin CGL2 from C. 
cinerea (3) and the B. thuringiensis crystal toxin 
Cry5B (15). These results suggest that binding of 
the lectin to a target glycan in the worm 
intestinal epithelium is essential for 
nematotoxicity. We hypothesize that the lectin is 
stored in the cytoplasm of the fungal cell and is 
released and transferred to the intestine of 
fungivorous nematodes upon predation. 
Using C. elegans genetics, we could identify 
the target glycoconjugate of MOA in this 
organism that is responsible for its toxicity. 
Similar to the nematotoxic Cry5B toxin from 
Bacillus thuringiensis, MOA binds to different 
species of the invertebrate-specific arthroseries 
of glycosphingolipids in C. elegans. Based on 
TLC overlays and MS analysis, the main species 
recognized by MOA is component D according 
to the annotation by Griffitts et al. (16). This 
finding is consistent with the genetic results as 
bre-3, bre-5 and bre-4 (but not bre-2) encode 
glycosyltransferases involved in the biosynthesis 
of this specific glycosphingolipid. In addition to 
this previously identified glycosphingolipid 
species, MOA bound to several unknown 
glycolipids present in N2 and bre-2(ye31) but 
not in the bre-4(ye27) mutant worms. These 
results indicate the presence of multiple 
additional glycosphingolipid species carrying 
terminal Galα1,3Gal in C. elegans. The full 
sensitivity of bre-1(ye4) worms suggests that in 
contrast to glycosphingolipid-binding Cry5B, 
fucosylation of the lipid is not required for MOA 
binding. 
The putative catalytic activity of MOA was 
investigated in in vitro assays with purified 
recombinant protein. In these assays, MOA 
showed proteolytic activity towards several 
native and denatured model substrates. The lack 
of activity towards some native protein 
substrates suggests a certain substrate specificity. 
The proteolytic activity of MOA was dependent 
on a cysteine residue in the predicted catalytic 
site, on the presence of Ca
2+
 and had a pH 
optimum of 8.0. The C-terminal domain of 
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MOA does not show homology to any existing 
proteinase family currently classified in the 
MEROPS database. Interestingly, the peptidase 
domain of MOA is the smallest in terms of 
residues that has ever been described and is even 
smaller than the HIV1 retropepsin. The crystal 
structure suggests that the active site cysteine is 
very close to the calcium binding sites, and the 
glutamine that would be an ideal candidate for 
forming the oxyanion hole is also a calcium 
ligand. Thus, the chemistry around the active site 
of this protease domain appears to be very ‘busy’ 
(N. D. Rawlings, personal communication).  
Intriguingly, we could show that, in addition 
to carbohydrate-binding, the proteolytic activity 
of MOA is required for full toxicity towards C. 
elegans as toxicity of a catalytic site mutant is 
decreased and toxic effects of MOA are reduced 
in the presence of the highly specific cysteine 
protease inhibitor E-64. The equal susceptibility 
of N2 and pmk-1(km25) worms towards wild 
type MOA, as opposed to catalytically inactive 
MOA variants, suggests that the catalytic 
activity adds an additional twist to this lectin 
with regard to its mechanism of toxicity. 
As determined by in vitro digests of different 
model substrates, MOA preferentially cleaves 
sequences with proline or valine at position P2. 
Interestingly, a similar sequence specificity has 
been described for calpains, a family of calcium-
dependent, non-lysosomal cysteine proteases 
that are expressed ubiquitously in mammals and 
many other organisms (21) and are involved in 
regulation of signal transduction pathways, cell 
motility, and apoptosis (22,23). In contrast to 
calpain that proteolyzes its substrates in a limited 
manner exhibiting modulatory functions by 
cutting interdomain regions, our analysis using 
model substrates suggests that MOA digests 
protein substrates to small peptides. The 
specificity for sequences containing proline may 
allow MOA to act on a wide range of proteins, 
as proline residues are generally located in turns 
at the protein surface. However, further studies 
with more physiological substrate proteins are 
required to strengthen this hypothesis. 
Chimeric lectins homologous to MOA are 
present in the basidiomycetes Polyporus 
squamosus (PSL) (24) and Schizophyllum 
commune (SCA) (25). In PSL, the catalytic triad 
and the four Asp residues taking part in Ca
2+
-
binding are conserved. The lectin domain of 
PSL, however, has been shown to be specific for 
Neu5Acα2,6Galβ1,4Glc/GlcNAc groups of N-
glycans (24,26,27). In contrast, SCA has a 
similar carbohydrate-binding specificity as MOA 
(will be published elsewhere) but the catalytic 
residues Cys, His and Glu of MOA are replaced 
by Ser, Ser and Asp, respectively, and only one 
of the four Asp residues involved in Ca
2+
-
binding is conserved suggesting that the cysteine 
protease activity is not conserved in this 
homologue.  
As one possible toxicity mechanism, binding 
of MOA to glycosphingolipids in the nematode 
intestinal epithelium may result in digestion of 
surrounding proteins and ultimately lead to 
disintegration of the intestinal epithelium. A 
similar mechanism has been proposed for the 
maize cysteine protease Mir1-CP, which has 
been shown to impair the growth of fall 
armyworm (Spodoptera frugiperda) larvae by 
disrupting the insect’s peritrophic matrix in the 
intestine (28-30). Such proteases are used by 
plants, besides lectins and protease inhibitors, as 
defense molecules against herbivores (31) in line 
with our hypothesis of MOA being involved in 
fungal defense. Interestingly, Mir1-CP was 
recently shown to synergize the insecticidal 
activity of Bacillus thuringiensis toxins (32). 
On the other hand, the carbohydrate-binding 
deficient but protease-proficient variant 
MOA(Q46A,W138A) was absolutely non-toxic 
even at the high lectin concentrations in the 
biotoxicity assay with recombinant bacteria (Fig. 
1) and the lumen of the C. elegans intestine is 
thought to be slightly acidic based on the pH 
optima of digestive hydrolases (33), arguing 
against such a mechanism. In addition, the 
nature of its ligand (receptor) as well as the 
structural and functional organization of MOA 
are strikingly similar to bacterial AB5 toxins 
such as the Cholera and the Shiga toxin. These 
proteins consist of a non-toxic B-subunit which 
binds to specific glycolipids and an 
enzymatically active A-subunit that induces 
toxicity by blocking the GTPase-activity of Gα 
and activating adenylate cyclase (Cholera toxin) 
or by inactivating ribosomal protein biosynthesis 
(Shiga toxin). The intoxication process by these 
proteins is initiated by attachment of the toxin 
via the B-subunit followed by internalization of 
the AB5-receptor complex by receptor mediated 
endocytosis and retrograde transport to the 
endoplasmic reticulum (ER) (34). Finally, the A-
subunit of these toxins is translocated to the 
cytoplasm by the sec translocon. This final step 
is omitted in the case of the subtilase cytotoxin 
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SubAB that induces cell death by exhibiting 
highly specific protease activity towards the ER-
resident chaperone BiP (35). It is remarkable that 
SubAB produces pathological features in mice 
that strongly resemble the hemolytic uraemic 
syndrome (HUS) in humans (35), a characteristic 
that has also been observed for MOA (36). 
These results suggest that SubAB and MOA may 
have a similar toxicity mechanism. In 
accordance with such a hypothesis, the 
combination of neutral pH (37) and a Ca
2+
 
concentration of more than 100 μM in the 
endoplasmic reticulum (38) meet the 
requirements of MOA to exhibit protease 
activity. On the other hand, MOA is not 
expected to be catalytically active at the neutral 
pH but low Ca
2+
 concentration (~ 100 nM) of the 
cytosol (37,39) which allows storage of this 
toxic protein in an inactive form in the 
cytoplasm of the fungal cell. Similarly, the 
slightly acidic pH in the intestinal lumen of the 
nematode should inhibit the proteolytic activity 
of MOA despite of the presumably high Ca
2+ 
concentrations in this compartment (33). Such a 
regulation of its proteolytic activity via pH and 
Ca
2+
 concentration could explain the apparent 
lack of autoproteolytic activation or of 
pronounced substrate specificity of MOA. We 
therefore hypothesize that, upon binding to the 
glycosphingolipid receptor present on intestinal 
epithelial cells in the nematode, MOA is 
internalized to the early endosomal compartment 
by endocytosis and transported via the Golgi to 
the ER, where its catalytic domain is activated 
and may induce toxicity by degrading proteins 
that are in the folding process (Fig. S8). Further 
experiments are required to corroborate this 
hypothetical toxicity mechanism. 
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FIGURE LEGENDS 
 
Figure 1. Recombinant MOA displays carbohydrate-binding dependent toxicity towards C. 
elegans. E. coli BL21(DE3) cells expressing MOA, the C-terminal deletion mutant MOA(C), the 
carbohydrate-binding deficient variant MOA(Q46A,W138A) or containing empty vector were fed to 
Caenorhabditis elegans wild type N2 and pmk1(km25) mutant worms. A. MOA inhibits C. elegans 
development. The fraction of C. elegans L1 larvae having developed to L4 stage was scored after 72 h 
of feeding on a lawn of respective E. coli BL21 cells. Columns represent the average of 9 biological 
replicates. Error bars indicate standard deviations. B. MOA damages the C. elegans intestine. L4 
larvae of C. elegans wild-type N2 were fed with MOA-expressing (lower panels) and control (upper 
panels) E. coli BL21(DE3) cells and examined after 24 h under the stereomicroscope (left panels) and 
by differential interference contrast (DIC) microscopy (right panels). Size bars, 20μm. 
 
Figure 2. Toxicity of MOA towards C. elegans is mediated by binding to glycosphingolipids. A. 
Identified insertion sites of Mos1 transposon in the bre-3 gene of MOA-resistant C. elegans mutants. 
Arrows above Mos1 elements indicate the orientation of the Mos1 primer oJL115 used for sequencing 
iPCR products of mutant lysates. Bold letters indicate C. elegans genomic sequences followed by 
Mos1 sequence. The gene model is taken from WormBase Release WS213. Clear boxes indicate 
exons and shaded boxes at the ends of the gene indicate 5'- and 3'-untranslated regions. B. Resistance 
of C. elegans bre-3(ye26), bre-4(ye27) and bre-5(ye17) mutants towards MOA-mediated toxicity. C. 
elegans mutants of the indicated genotypes were analyzed for development from L1 to L4 as outlined 
above. Columns represent the average of 9 biological replicates. Error bars indicate standard 
deviations. C. MOA binds glycolipids of N2 and bre-2(ye31) but not bre-4(ye27) animals. Lipids 
were extracted from N2, bre-2(ye31) and bre-4(ye27) worms, resolved by TLC and stained with 
orcinol (lane 2-4) or overlaid with biotinylated Cry5B (lane 1) or MOA (lanes 5-7). The origin is 
always at the bottom. Letters refers to the glycolipid classification by Griffitts et al. (16). D. Tentative 
structure of the main glycosphingolipid species (component D) recognized by MOA. The core of the 
ceramide(Cer)-linked oligosaccharide is synthesized by BRE-3, BRE-5 and BRE-4. The terminal 
α1,3Gal is added by a yet unknown galactosyltransferase. 
 
Figure 3. Purified recombinant MOA shows in vitro protease activity. In vitro protease activity of 
MOA using denatured RNase A as substrate. 0.5 (A, B) or 1 μg (C) of purified recombinant MOA and 
MOA(C215A) were incubated with 20 μg of denatured RNase A in assay buffer (40 mM Tris-HCl pH 
8.0, 1 mM CaCl2, 1% NP-40) for 1 h at 37 °C. The reaction was stopped by addition of SDS sample 
buffer and heating at 95 °C for 10 min. Samples were analyzed by SDS-PAGE and Coomassie blue 
staining. m, molecular weight standard. A. Catalytic activity of MOA is dependent on residue C215 
and abolished by cysteine protease inhibitor E-64. MOA was incubated with 50 μM E-64, 2 mM 
PMSF and 2 mM AgNO3 for 20 min at RT before the substrate was added. B. Ca
2+
 is required for 
protease activity of MOA. The reaction was performed in assay buffer w/o CaCl2 as well as in buffer 
containing 1mM CaCl2, MgCl2, MnCl2, and ZnCl2 respectively. C. MOA protease activity has an 
alkaline pH optimum. Buffers at different pH values ranging from 4.5 to 9.7 were supplemented with 
1mM CaCl2 and 1% NP-40 and used as assay buffers. D. Cleavage site specificity of MOA. The 
iceLogo (20) was generated from 83 MOA-induced cleavage sites in native model substrates (bovine 
asialofetuin, bovine casein and human hemoglobin). MOA-mediated cleavage occurs between 
position 4 and 5 of the sequence logo. 
 
Figure 4. Protease activity of MOA is required for full toxicity towards C. elegans. A. 
MOA(C215A) exhibits reduced toxicity towards C. elegans. C. elegans wild-type N2 and 
pmk1(km25) mutants were seeded onto lawns of E. coli BL21(DE3) cells expressing MOA, 
MOA(C215A) or containing empty vector and analyzed for development from L1 to L4 as described 
above. Columns represent the average of 9 biological replicates. Error bars indicate standard 
deviations. B. Cysteine protease inhibitor E-64 diminishes MOA-mediated toxicity towards C. 
elegans. L1 staged C. elegans pmk-1(km25) worms were seeded onto a lawn of E. coli BL21(DE3) 
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expressing MOA mixed with E-64 diluted in M9 buffer at the indicated concentrations. Development 
of the animals from L1 to L4 was analyzed as outlined above. As a control the experiment was 
performed with E. coli BL21(DE3) containing empty vector. Data shown represent the average of 9 
biological replicates. Error bars indicate standard deviations. 
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Figure 1 
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Figure 2 
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Figure 4 
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